Thursday, Jan 08th
Last update08:51:27 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
|
 The Department of Health and Human Services is freezing all childcare payments to all states, an... | ||
 The Trump administration is facing a legal complaint from a group of government employees affected by... |
 Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —... |
